Abstract:Experimental models of the central nervous system (CNS) are imperative for developmental and pathophysiological studies of neurological diseases. Among these models, three-dimensional (3D) induced pluripotent stem cell (iPSC)-derived brain organoid models have been successful in mitigating some of the drawbacks of 2D models; however, they are plagued by high organoid-to-organoid variability, making it difficult to compare specific gene regulatory pathways across 3D organoids with those of the native brain. Single-cell RNA sequencing (scRNA-seq) transcriptome datasets have recently emerged as powerful tools to perform integrative analyses and compare variability across organoids. However, transcriptome studies focusing on late-stage neural functionality development have been underexplored. Here, we combine and analyze 8 brain organoid transcriptome databases to study the correlation between differentiation protocols and their resulting cellular functionality across various 3D organoid and exogenous brain models. We utilize dimensionality reduction methods including principal component analysis (PCA) and uniform manifold approximation projection (UMAP) to identify and visualize cellular diversity among 3D models and subsequently use gene set enrichment analysis (GSEA) and developmental trajectory inference to quantify neuronal behaviors such as axon guidance, synapse transmission and action potential. We showed high similarity in cellular composition, cellular differentiation pathways and expression of functional genes in human brain organoids during induction and differentiation phases, i.e., up to 3 months in culture. However, during the maturation phase, i.e., 6-month timepoint, we observed significant developmental deficits and depletion of neuronal and astrocytes functional genes as indicated by our GSEA results. Our results caution against use of organoids to model pathophysiology and drug response at this advanced time point and provide insights to tune in vitro iPSC differentiation protocols to achieve desired neuronal functionality and improve current protocols.

A Focused Microarray to Assess Dopaminergic and Glial Cell Differentiation from Fetal Tissue or Embryonic Stem Cells

A chemical genomics screen to discover genes that modulate neural stem cell differentiation.

Genome Wide Profiling of Dopaminergic Neurons Derived from Human Embryonic and Induced Pluripotent Stem Cells.

Gene Expression Analysis in Stem Cell-derived Cortical Neuronal Cultures Using Multi-well SYBR Green Quantitative PCR Arrays

Three dimensional cellular microarray platform for human neural stem cell differentiation and toxicology

[Phenotype-Based Primary Screening for Drugs Promoting Neuronal Subtype Differentiation in Embryonic Stem Cells with Light Microscope].

High-throughput identification of factors promoting neuronal differentiation of human neural progenitor cells in microscale 3D cell culture

BrainSTEM: A multi-resolution fetal brain atlas to assess the fidelity of human midbrain cultures

Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain

3D-cultured neural stem cell microarrays on a micropillar chip for high-throughput developmental neurotoxicology

Directed Neuronal Differentiation of Mouse Embryonic and Induced Pluripotent Stem Cells and Their Gene Expression Profiles

182 Purification and Characterization of Human Neural Stem and Progenitor Cells

Differentiation of Neural Precursors and Dopaminergic Neurons from Human Embryonic Stem Cells.

A High-content Screen Identifies Compounds Promoting the Neuronal Differentiation and the Midbrain Dopamine Neuron Specification of Human Neural Progenitor Cells

Proteomic Characterization of Early-Stage Differentiation of Mouse Embryonic Stem Cells into Neural Cells Induced by All-Trans Retinoic Acid in Vitro.

Microarray Analysis of Neural Stem Cell Differentiation in the Striatum of the Fetal Rat

Screening for Best Neuronal-Glial Differentiation Protocols of Neuralizing Agents Using a Multi-Sized Microfluidic Embryoid Body Array

Identifying Genes that Affect Differentiation of Human Neural Stem Cells and Myelination of Mature Oligodendrocytes

Cell Type Specific Analysis of Human Brain Transcriptome Data to Predict Alterations in Cellular Composition.

Differential display of proteins involved in the neural differentiation of mouse embryonic carcinoma P19 cells by comparative proteomic analysis.

Transcriptomic Mapping of Neural Diversity, Differentiation and Functional Trajectory in iPSC-Derived 3D Brain Organoid Models